Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years

Abroad (travel likely)RecruitingPHASE1

Conditions

Malaria, Falciparum

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

GSK Investigational Site, Miami, Florida, United States
Contact: Study coordinator (US GSK Clinical Trials Call Center) · GSKClinicalSupportHD@gsk.com · 877-379-3718
Contact: Study coordinator (EU GSK Clinical Trials Call Centre) · GSKClinicalSupportHD@gsk.com · +44 (0) 20 8990 4466
Contact: Principal Investigator (Sandra Pagnussat)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants

Malaria, Falciparum

Abroad (travel likely)RecruitingPHASE1

Nottingham, United Kingdom

Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates

Malaria

Abroad (travel likely)Recruiting

Bamako, Mali

A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

Malaria

Abroad (travel likely)RecruitingPHASE2

Kigali, Rwanda · Kigali, Rwanda

Malaria Molecular Surveillance in Mozambique (Phase 2)

Malaria · Falciparum Malaria · Malaria in Pregnancy

Abroad (travel likely)Recruiting

Manhiça, Mozambique